éå»1ã¶æéã«Rapport Therapeutics Incã«å¯ŸããŠè©äŸ¡ãåºããã¢ããªã¹ã13åã«åºã¥ãããŒã¿ã
仿ãRAPPã¯7ä»¶ã®ãè²·ããã0ä»¶ã®ãäžç«ïŒããŒã«ãïŒãã0ä»¶ã®ã売ããè©äŸ¡ãç²åŸããŸãããçŽè¿1ã¶æã«ãããRAPPã®ã¢ããªã¹ãå¹³åç®æšæ ªäŸ¡ã¯68.286ã§ãã
ã¢ããªã¹ãäºæ³ã«ãããšãFY2026Q3ã«çºè¡šãããEPS -0.842ã«ç¶ããRAPPã®FY2026Q4ã®EPSã¯-1.011ã«éããèŠéãã§ããçºè¡šãããå®çžŸå€ãšäºæ³ãæ¯èŒããŠãåçæ§ã®æšç§»ã確èªããŸãããã
åžå Žäºæ³ã¯ USD -0.84 ã§ããããRapport Therapeutics IncRAPP ã®åååæã®äžæ ªåœããå©ç (EPS) 㯠USD -1.19 ã§ãããæ¬¡ã®ååæã® EPS 㯠USD -1.01 ãšäºæ³ãããŸãã